Feasibility of Study of Empagliflozin in Patients With Autosomal Dominant Polycystic Kidney Disease
Condition: Polycystic Kidney, Autosomal Dominant Interventions: Drug: Empagliflozin; Drug: Placebo Sponsors: University of Colorado, Denver; University of Maryland Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Empagliflozin | Jardiance | Polycystic Kidney Disease | Research | Study | Urology & Nephrology